Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

NCT01397422 is registered in ClinicalTrials.gov with Adamas Pharmaceuticals, Inc. as lead sponsor.

NCT NCT01397422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Lead sponsor
Adamas Pharmaceuticals, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2011
Completion date
October 31, 2013
Enrollment
83 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesia, levodopa induced dyskinesia, parkinson's disease